Association of DIO2 Thr92Ala Polymorphism With Pediatric Obesity In Japanese Children: A Case Control Study

Takeshi Ota,Jun Mori,Hirotsugu Yasuda,Mihoko Yamaguchi,Satoshi Miyagaki,Yasuhiro Kawabe,Yusuke Tsuma,Hidechika Morimoto,Keiichi Shigehara,Shota Fukuhara,Kazuki Kodo,Satoru Sugimoto,Kitaro Kosaka,Hisakazu Nakajima,Hajime Hosoi
DOI: https://doi.org/10.21203/rs.3.rs-131077/v1
2020-12-28
Abstract:Abstract Background Genetic factors play a critical role in the onset and progression of obesity. Brown adipose tissue (BAT) activity is also critical for adiposity. The objective of this study was to evaluate the prevalence and effects of gene polymorphisms related to BAT in pediatric obesity. Methods A case-control study with 270 non-obese and 86 obese children was performed. All participants underwent genotyping of type 2 deiodinase (DIO2) Thr92Ala (rs225014), uncoupling protein 1 (UCP1) -3826 A/G (rs1800592), and β3 adrenergic receptor (β3AR) Trp64Arg (rs4994). Results In the case-control study, the prevalence of the homozygous Ala/Ala allele of the DIO2 gene in the obese group was 15.1 % versus 6.3 % in the non-obese group, resulting in an odds ratio (OR) of 3.393 (95% confidence intervals [CI], 1.498-7.687, P = 0.003). The genotype distribution of UCP1-3826 A/G and ß3AR Trp64Arg did not significantly differ between the obese and the non-obese groups, and the ORs were 1.831 (95% CI, 0.955-3.512, P = 0.069) and 0.819 (95% CI, 0.263-2.555, P = 0.731), respectively. Conclusions Our results indicate that the homozygous Ala/Ala allele of the DIO2 gene is associated with an increased risk of obesity in children.
What problem does this paper attempt to address?